New cancer clinical trial: Version: V1.1 8/15/2017 A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer
Published on: October 04, 2017 at 10:00AM
Condition: Pancreatic Cancer
Intervention: Drug: Paricalcitol
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting
http://ift.tt/2gbGe3u
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM